TEMPE, Ariz.--(BUSINESS WIRE)--Radiant Clinical Research (Radiant), the country’s largest and fastest-growing network of wholly-owned integrated clinical trial sites, is expanding the scope of its Central Nervous System (CNS) studies. This expansion is in response to a growing need for qualified sites that have the expertise to conduct pharmaceutical trials for the treatment of schizophrenia, bipolar disorder, depression, Alzheimer’s and other CNS conditions.
